Search by Drug Name or NDC

NDC 33342-0314-11 Propylthiouracil 50 mg/1 Details

Propylthiouracil 50 mg/1

Propylthiouracil is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Macleods Pharmaceuticals Limited. The primary component is PROPYLTHIOURACIL.

MedlinePlus Drug Summary

Propylthiouracil is used to treat hyperthyroidism (a condition that occurs when the thyroid gland produces too much thyroid hormone, speeding the body's metabolism, and causing certain symptoms) in adults and children 6 years of age or older. Propylthiouracil is in a class of medications called antithyroid agents. It works by stopping the thyroid gland from making thyroid hormone.

Related Packages: 33342-0314-11
Last Updated: 03/24/2024
MedLinePlus Full Drug Details: Propylthiouracil

Product Information

NDC	33342-0314
Product ID	33342-314_a251e4cb-01f1-4fd8-bd30-362126b85073
Associated GPIs
GCN Sequence Number	006673
GCN Sequence Number Description	propylthiouracil TABLET 50 MG ORAL
HIC3	P3L
HIC3 Description	ANTITHYROID PREPARATIONS
GCN	26391
HICL Sequence Number	002854
HICL Sequence Number Description	PROPYLTHIOURACIL
Brand/Generic	Generic
Proprietary Name	Propylthiouracil
Proprietary Name Suffix	n/a
Non-Proprietary Name	Propylthiouracil
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	50
Active Ingredient Units	mg/1
Substance Name	PROPYLTHIOURACIL
Labeler Name	Macleods Pharmaceuticals Limited
Pharmaceutical Class	Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA208867
Listing Certified Through	2024-12-31

Package

NDC 33342-0314-11 (33342031411)

Pricing Information	N/A
NDC Package Code	33342-314-11
Billing NDC	33342031411
Package	100 TABLET in 1 BOTTLE (33342-314-11)
Marketing Start Date	2023-05-10
NDC Exclude Flag	N